These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9151532)

  • 21. Airway epithelial cell release of cytokines: modulation by various therapeutic agents.
    Frieri M
    Allergy Asthma Proc; 2004; 25(6):387-93. PubMed ID: 15709449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and airway function in asthma: what you see is not necessarily what you get.
    Haley KJ; Drazen JM
    Am J Respir Crit Care Med; 1998 Jan; 157(1):1-3. PubMed ID: 9445269
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytokine antagonists for the treatment of asthma: progress to date.
    Antoniu SA
    BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alveolar nitric oxide concentration, small airways inflammation, and targeted asthma therapy: are we there yet?
    Kelly HW
    J Allergy Clin Immunol; 2010 Oct; 126(4):736-7. PubMed ID: 20920762
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic implications of 'neutrophilic asthma'.
    Nair P; Aziz-Ur-Rehman A; Radford K
    Curr Opin Pulm Med; 2015 Jan; 21(1):33-8. PubMed ID: 25415406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling-.
    Yamauchi K; Inoue H
    Allergol Int; 2007 Dec; 56(4):321-9. PubMed ID: 17965575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
    Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukotriene generation and clinical implications.
    Arm JP
    Allergy Asthma Proc; 2004; 25(1):37-42. PubMed ID: 15055561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
    Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
    J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel approaches to the inhibition of cytokine responses in asthma.
    Higgs OA
    J Pharm Pharmacol; 1997 May; 49 Suppl 3():25-31. PubMed ID: 9178204
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease.
    Xiong Y; Wang J; Wu F; Li J; Zhou L; Kong L
    Eur J Pharmacol; 2012 May; 683(1-3):316-24. PubMed ID: 22449378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The allergic cascade: review of the most important molecules in the asthmatic lung.
    Bloemen K; Verstraelen S; Van Den Heuvel R; Witters H; Nelissen I; Schoeters G
    Immunol Lett; 2007 Oct; 113(1):6-18. PubMed ID: 17765979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mediators of inflammatory response in asthma and its association with obesity].
    Galicia-Negrete G; Falfán-Valencia R
    Rev Alerg Mex; 2017; 64(2):198-205. PubMed ID: 28658728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
    Lanz MJ; Leung DY; White CW
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiarellic acid attenuates airway hyperresponsiveness and inflammation in a murine model of allergic asthma.
    Lee MY; Ahn KS; Lim HS; Yuk JE; Kwon OK; Lee KY; Lee HK; Oh SR
    Int Immunopharmacol; 2012 Jan; 12(1):117-24. PubMed ID: 22085848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New approaches to treatment of occupational bronchial asthma].
    Petrykina MV; Kuz'mina LP; Sorkina NS
    Med Tr Prom Ekol; 2010; (7):33-6. PubMed ID: 20853629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of kaempferol-3-O-rhamnoside on ovalbumin-induced lung inflammation in a mouse model of allergic asthma.
    Chung MJ; Pandey RP; Choi JW; Sohng JK; Choi DJ; Park YI
    Int Immunopharmacol; 2015 Apr; 25(2):302-10. PubMed ID: 25698556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical inquiries. Is nedocromil effective in preventing asthmatic attacks in patients with asthma?
    Dudley T; Parker S; Baldwin R
    J Fam Pract; 2004 Nov; 53(11):927-8. PubMed ID: 15527735
    [No Abstract]   [Full Text] [Related]  

  • 40. Can corticosteroids be beaten in future asthma therapy?
    Amon A; Pahl A; Szelenyi I
    Pharmazie; 2006 Feb; 61(2):122-4. PubMed ID: 16526559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.